Janet Shimotake, MD
Associate Professor
Pediatrics
School of Medicine

Education & Training

Show all (3) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 2019
• Pediatrics Residency University of Chicago Comer Children's Hospital 06/2003
• MD University of Chicago, Pritzker SOM 06/1999

Publications (2)

Top publication keywords:
Neovascularization, PhysiologicPyrrolesVascular Endothelial Growth Factor Receptor-2Animals, NewbornIndolesCalpainInfarction, Middle Cerebral ArteryCerebral ArteriesCaspase 3StrokeRats, Sprague-DawleyEndothelial CellsNecrosisVascular Endothelial Growth Factor AAngiogenesis Inhibitors

• In Utero Hematopoietic Cell Transplantation in Fetuses with Alpha Thalassemia Major: A Phase 1 Clinical Trial.
  Blood advances 2026 MacKenzie TC, Lianoglou BR, Gonzalez J, Dvorak CC, Kharbanda S, Herzeg A, Canepa E, Kreger EM, Frascoli M, Sper R, Gupta A, Leung J, Tang Q, Sinha R, Worthington AK, Gano D, Coco Bakkour S, Chafets D,…
• Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke.
  Stroke 2010 Shimotake J, Derugin N, Wendland M, Vexler ZS, Ferriero DM